For the people leading communication and marketing efforts in the pharmaceutical industry, enhancing the performance of their brands means ensuring maximum return on investment, however long that return takes.
Achieving this takes more than simply carrying out clever marketing campaigns. Strategies need to be carefully considered to ensure content triggers the right emotions in target audiences to drive them to take the desired action.
How can marketers deliver this for their companies? Can behavioral economics, combined with AI (artificial intelligence) help?
Roy Rogers, Director at Research Partnership, an Inizio Advisory company, explores how understanding behavioral economics is essential to delivering more effective brand performance for pharmaceutical companies.
To find out more, click here.
Jump to a slide with the slide dots.
Discover how Inizio is harnessing AI with intent to redefine pharma and progress across the healthcare landscape.
Read more
Richard Lawrence
The pharmaceutical industry is in a constant state of change, driven by shifting demands and increasing complexity. Within this evolving landscape, th
Read moreAs obesity science continues to evolve, so too does the opportunity for pharma to lead with purpose. Obesity Week 2025 will spotlight this evolution.
Read more